Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition containing sequoyitol as well as preparation method and application thereof

A composition and a technique of seclitaxel, which are applied in the field of pharmaceutical compositions containing seclitaxel and the preparation thereof, can solve the problems of no disclosure of the application of seclitaxel compositions, no hepatoprotective drugs, and no hepatoprotective drugs. , to achieve the effect of low price, safe medication and clear ingredients

Inactive Publication Date: 2018-03-06
朗致集团江西医药有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the hepatoprotective drug with single component of pinitol and paclitaxel as the active ingredient has not been reported in China, and there is no report of the hepatoprotective drug with the composition formed by mixing pinitol and paclitaxel as the active ingredient; The application of the composition formed by total flavonol glycosides, ginkgolides, pinitol, and paclitaxel for liver protection has been disclosed, and there is no liver protection product in the form of its composition as the raw material drug on the market. drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition containing sequoyitol as well as preparation method and application thereof
  • Pharmaceutical composition containing sequoyitol as well as preparation method and application thereof
  • Pharmaceutical composition containing sequoyitol as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] The pharmaceutical composition containing paclitaxel in this embodiment includes the following components: paclitaxel 3mg, pinitol 20mg;

[0046] The above-mentioned selected parts by weight of paclitaxel, pinitol, water, and auxiliary materials are mixed to form a sterile solution with a pH value of 7.0, wherein the content of the paclitaxel in the sterile solution is 0.3 mg / mL, The content of the pinitol in the sterile solution is 2mg / mL.

Embodiment 2

[0048]The pharmaceutical composition containing paclitaxel in this embodiment includes the following components: paclitaxel 4mg, pinitol 15mg, ginkgolide A 2mg, ginkgolide B 1mg, ginkgolide C 0.4mg, narcissin 0.9mg, Protol-3-O-[6-O-(α-L-rhamnosyl)]-β-D-glucoside 0.3mg;

[0049] The above-mentioned seclitaxel, pinitol, ginkgolide A, ginkgolide B, ginkgolide C, narciscin and kaempferol-3-O-[6-O-(α-L- Rhamnosyl)]-β-D-glucoside is mixed with water and auxiliary materials to make a sterile solution with a pH value of 5.0, wherein the content of the paclitaxel in the sterile solution is 0.4mg / mL, The content of the pinitol in the sterile solution is 1.5mg / mL.

Embodiment 3

[0051] The pharmaceutical composition containing paclitaxel in this embodiment includes the following components: paclitaxel 4.5 mg, pinitol 20 mg, ginkgolide A 1.8 mg, ginkgolide B 0.9 mg, ginkgolide C 0.4 mg, narciscin 0.1 mg, kaempferol-3-O-[6-O-(α-L-rhamnosyl)]-β-D-glucoside 0.9mg;

[0052] The above-mentioned seclitaxel, pinitol, ginkgolide A, ginkgolide B, ginkgolide C, narciscin and kaempferol-3-O-[6-O-(α-L- Rhamnosyl)]-β-D-glucoside is mixed with water and auxiliary materials to make a sterile solution with a pH value of 5.0, wherein the content of the paclitaxel in the sterile solution is 0.45mg / mL, The content of the pinitol in the sterile solution is 2mg / mL.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition containing sequoyitol as well as a preparation method and application thereof. The pharmaceutical composition is prepared from the following components according to the specific weight part: pinitol and the sequoyitol; all crude drugs have mutual matching and common effects under the specific ratio, so that the composition provided by the invention has a remarkable liver-protecting effect.

Description

technical field [0001] The invention relates to the field of pharmaceutical compositions, in particular to a pharmaceutical composition containing paclitaxel, a preparation method and application thereof. Background technique [0002] The liver is the largest digestive gland in the human body. It not only secretes bile to participate in digestion, but also has important functions such as nutrient metabolism, glycogen storage, detoxification, and phagocytosis defense. Bad eating habits are an important cause of liver damage. Bad eating habits can cause metabolic and physiological disorders in the body, cause physical and psychological balance, and then lead to liver dysfunction and liver damage. [0003] my country is one of the countries with a high incidence of liver disease. At present, the western medicines used to treat liver diseases mainly include antiviral drugs, immunomodulatory drugs, and liver-protecting and enzyme-lowering drugs. The above-mentioned drugs all hav...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61K31/075A61K31/365A61P1/16
CPCA61K31/075A61K31/365A61K31/7048A61K36/16A61K2300/00
Inventor 王锋杨满辉
Owner 朗致集团江西医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com